Skip to content
healthcare.dev

Terconazole

NDC 45802-717, Terconazole, suppository, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-717
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SUPPOSITORY
Route
VAGINAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077149
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERCONAZOLE80 mg/1

Pharmacologic classes

Azole Antifungal [EPC]; Azoles [CS]

Package NDCNDC-11Package
45802-717-08458020717083 BLISTER PACK in 1 CARTON (45802-717-08) / 1 SUPPOSITORY in 1 BLISTER PACK (45802-717-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/207e9cf2-e8ec-43d7-9c11-46283c9cdb37
  • NADAC price for package 45802071708

    GET /v1/drugs/nadac/45802071708

Use it

Look up 45802-717 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-717 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.